Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures

References

1. Bryan J. P., Iqbal M., Ksiazek T. G. & 10 other authors; 1996; Prevalence of sand fly fever, West Nile, Crimean-Congo hemorrhagic fever, and leptospirosis antibodies in Pakistani military personnel. Mil Med 161:149–153
   [Google Scholar]
2. Burt F. J., Leman P. A., Smith J. F., Swanepoel R. 1998; The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean-Congo haemorrhagic fever. J Virol Methods 70:129–137 [CrossRef]
   [Google Scholar]
3. Crowcroft N. S., Morgan D., Brown D. 2002; Viral haemorrhagic fevers in Europe – effective control requires a co-ordinated response. Euro Surveill 7:31–32
   [Google Scholar]
4. el-Azazy O. M., Scrimgeour E. M. 1997; Crimean-Congo haemorrhagic fever virus infection in the western province of Saudi Arabia. Trans R Soc Trop Med Hyg 91:275–278 [CrossRef]
   [Google Scholar]
5. Ergonul O., Celikbas A., Dokuzoguz B., Eren S., Baykam N., Esener H. 2004; Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 39:284–287 [CrossRef]
   [Google Scholar]
6. Fisher-Hoch S. P., Khan J. A., Rehman S., Mirza S., Khurshid M., McCormick J. B. 1995; Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346:472–475 [CrossRef]
   [Google Scholar]
7. Isaacson M. 2001; Viral hemorrhagic fever hazards for travelers in Africa. Clin Infect Dis 33:1707–1712 [CrossRef]
   [Google Scholar]
8. Khan A. S., Maupin G. O., Rollin P. E. & 9 other authors; 1997; An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. Am J Trop Med Hyg 57:519–525
   [Google Scholar]
9. Mardani M., Jahromi M. K., Naieni K. H., Zeinali M. 2003; The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin Infect Dis 36:1613–1618 [CrossRef]
   [Google Scholar]
10. Papa A., Bozovi B., Pavlidou V., Papadimitriou E., Pelemis M., Antoniadis A. 2002; Genetic detection and isolation of crimean-congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg Infect Dis 8:852–854 [CrossRef]
    [Google Scholar]
11. Saidi S., Casals J., Faghih M. A. 1975; Crimean hemorrhagic fever-Congo (CHF-C) virus antibodies in man, and in domestic and small mammals, in Iran. Am J Trop Med Hyg 24:353–357
    [Google Scholar]
12. Sidwell R. W., Smee D. F. 2003; Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control. Antiviral Res 57:101–111 [CrossRef]
    [Google Scholar]
13. Tignor G. H., Hanham C. A. 1993; Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res 22:309–325 [CrossRef]
    [Google Scholar]
14. van Eeden P. J., van Eeden S. F., Joubert J. R., King J. B., van de Wal B. W., Michell W. L. 1985; A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II: Management of patients. S Afr Med J 68:718–721
    [Google Scholar]
15. Watts D. M., Ussery M. A., Nash D., Peters C. J. 1989; Inhibition of Crimean-Congo haemorrhagic fever viral infectivity yields in vitro by ribavirin. Am J Trop Med Hyg 41:581–585
    [Google Scholar]